Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISPS study of Qishen Yiqi dripping pill for secondary prevention after myocardial infarction
ChiCTR-PRC-06000002Phase 4Completed
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qishenyiqi Dripping Pills and aspirin in myocardial infarction (MI) (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoint: Composite endpoint events. Started Jan 2006; status: completed.
02
Drugs
Qishenyiqi Dripping Pillsaspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-PRC-06000002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-06000002.